TherapeuticsMD, Inc. (29TA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 03:46PM CEST. Market open.
| Previous close | 9.75 |
| Open | 9.50 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 9.50 - 9.75 |
| 52-week range | 1.90 - 44.50 |
| Volume | |
| Avg. volume | 11 |
| Market cap | 85.9M |
| Beta (5Y monthly) | 1.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -20.66 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireTherapeuticsMD Announces Full Year 2023 Financial Results
BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.
Business WireTherapeuticsMD Announces Third Quarter 2023 Financial Results
BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.
Business WireTherapeuticsMD Announces Second Quarter 2023 Financial Results
BOCA RATON, Fla., August 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023.
© 2024 Yahoo. All rights reserved.